CN114028493A - Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof - Google Patents
Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof Download PDFInfo
- Publication number
- CN114028493A CN114028493A CN202111587897.9A CN202111587897A CN114028493A CN 114028493 A CN114028493 A CN 114028493A CN 202111587897 A CN202111587897 A CN 202111587897A CN 114028493 A CN114028493 A CN 114028493A
- Authority
- CN
- China
- Prior art keywords
- parts
- red
- weight
- granules
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 64
- 210000003141 lower extremity Anatomy 0.000 title claims abstract description 60
- 206010046996 Varicose vein Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000003814 drug Substances 0.000 claims abstract description 42
- 239000002245 particle Substances 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 33
- 239000000463 material Substances 0.000 claims abstract description 32
- 238000001035 drying Methods 0.000 claims abstract description 30
- 244000124209 Crocus sativus Species 0.000 claims abstract description 29
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 29
- 240000000249 Morus alba Species 0.000 claims abstract description 29
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 29
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 29
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 29
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 28
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 28
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 28
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 28
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 26
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 26
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 26
- 238000001816 cooling Methods 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 239000007931 coated granule Substances 0.000 claims abstract description 18
- 239000000080 wetting agent Substances 0.000 claims abstract description 17
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 241000220259 Raphanus Species 0.000 claims description 27
- 238000009835 boiling Methods 0.000 claims description 20
- 235000013974 saffron Nutrition 0.000 claims description 19
- 239000004248 saffron Substances 0.000 claims description 19
- 229920001353 Dextrin Polymers 0.000 claims description 17
- 239000004375 Dextrin Substances 0.000 claims description 17
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 17
- 235000019425 dextrin Nutrition 0.000 claims description 17
- 239000008101 lactose Substances 0.000 claims description 17
- 102100036514 Amyloid-beta A4 precursor protein-binding family A member 1 Human genes 0.000 claims description 3
- 101710093637 Amyloid-beta A4 precursor protein-binding family A member 1 Proteins 0.000 claims description 3
- 238000007920 subcutaneous administration Methods 0.000 abstract description 16
- 230000008961 swelling Effects 0.000 abstract description 14
- 206010030113 Oedema Diseases 0.000 abstract description 3
- 210000003414 extremity Anatomy 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 2
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 abstract 1
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 abstract 1
- 235000018889 capsanthin Nutrition 0.000 abstract 1
- 235000012658 paprika extract Nutrition 0.000 abstract 1
- 239000001688 paprika extract Substances 0.000 abstract 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 48
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 24
- 229940074391 gallic acid Drugs 0.000 description 24
- 235000004515 gallic acid Nutrition 0.000 description 24
- 235000005493 rutin Nutrition 0.000 description 24
- 229960004555 rutoside Drugs 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 20
- 239000000523 sample Substances 0.000 description 17
- 206010060708 Induration Diseases 0.000 description 15
- 206010040943 Skin Ulcer Diseases 0.000 description 14
- 231100000019 skin ulcer Toxicity 0.000 description 14
- 206010042674 Swelling Diseases 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 12
- 239000002671 adjuvant Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 9
- 238000005303 weighing Methods 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 238000002552 multiple reaction monitoring Methods 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000010731 swelling symptom Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000132446 Inula Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicine-food homologous red-coated particle for varicose vein of lower limb and a preparation method thereof, aiming at solving the problems that the medicine for treating varicose vein of lower limb in the prior art is mainly a potion, has short storage time and is inconvenient to drink. The medicinal and edible capsanthin granules comprise the following raw materials in parts by weight: 1-5 parts of raspberry, 1-5 parts of crocus sativus, 1-3 parts of kudzu root, 1-3 parts of mulberry fruit, 1-5 parts of radish seed, 1-3 parts of allium macrostemon and 1-3 parts of mint. The preparation method comprises the following steps: adding 2000 parts by volume of water into the raw material composition, decocting, cooling, and filtering to obtain decoction dregs; adding 1500 parts by volume of water into the dregs of a decoction, decocting, cooling and compressing to obtain brown viscous paste, and drying to obtain traditional Chinese medicine extract powder; mixing the traditional Chinese medicine extract powder and auxiliary materials according to the weight ratio of 1:1, adding 70% of wetting agent ethanol, and drying to obtain the red-coated granules. The coated red granule can be used for treating lower limb venous distention, limb soreness, swelling, pain, subcutaneous stasis, induration, and edema.
Description
Technical Field
The invention belongs to the technical field of medicines for varicose vein of lower limbs, and particularly relates to medicine-food homologous red-coated granules for varicose vein of lower limbs and a preparation method thereof.
Background
Varicose Vein (LEVV) of lower limb is a common and frequently encountered clinical disease. LEVV has no obvious discomfort in the early stage, the disease condition develops, and patients have the symptoms of heavy limbs, soreness, distending pain, fatigue and the like. After the patient stands for a long time, edema and leg muscle spasm can occur in the foot boot area, and lower limb eczema or ulcer and pigmentation can be caused to affect the life quality of the patient when the treatment is not timely performed.
The existing medicine for treating varicose vein of lower limb mainly is a potion, has the problems of short preservation time, inconvenient drinking and poor treatment effect, and has larger side effect.
Disclosure of Invention
The invention provides a medicine-food homologous red-coated particle for varicose vein of lower limb and a preparation method thereof, aiming at solving the problems that the medicine for treating varicose vein of lower limb in the prior art is mainly a potion, has short storage time and is inconvenient to drink.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
in a first aspect, the invention provides a medicine-food homologous red-coated particle for varicose vein of lower limbs, which comprises the following raw materials in parts by weight: 1-5 parts of raspberry, 1-5 parts of crocus sativus, 1-3 parts of kudzu root, 1-3 parts of mulberry fruit, 1-5 parts of radish seed, 1-3 parts of allium macrostemon and 1-3 parts of mint.
Wherein, the raspberry: warm in nature, sweet in flavor and sour. Entering kidney meridian and bladder meridian; tonifying kidney, arresting spontaneous emission, and reducing urination. They belong to the group of herbs with astringents to secure essence, reduce urination and stop leukorrhagia.
Wherein, saffron: has the effects of promoting blood circulation, removing blood stasis, cooling blood, removing toxic substances, relieving depression and tranquilizing, and is mainly used for treating the clinical manifestations of amenorrhea, abdominal mass, postpartum stasis, warm toxicity, macula, melancholy, stuffiness, palpitation and mania, etc. in the body.
Wherein, mulberry fruit: expanding the blood volume of human body, and enhancing the immunity of the organism by the hematopoietic function; strengthening spleen and stomach, promoting digestion, and promoting digestion, wherein the nutrient substances such as fatty acid, malic acid, etc. can help fat, protein, and starch to digest and absorb, and enhance intestinal motility; it also can make hair black and bright.
Wherein, root of kudzu vine: has antipyretic, anticoagulant, and spasmolytic effects; lowering blood pressure, increasing coronary blood flow and cerebral blood flow, improving microcirculation, increasing nutrition supply, and reducing cholesterol and blood viscosity; promoting osteoblast proliferation and differentiation, and promoting children intelligence; accelerating the blood circulation of retina and improving the visual function; inhibiting dysentery bacillus and resisting cancer.
Wherein, the macrostem onion: the flavor is pungent, warm and bitter, and enters heart, lung, stomach and large intestine meridians, activating yang and dissipating nodulation, and moving qi and removing stagnation.
Wherein, the mint: pungent in nature and taste, cool, enter lung and liver meridians, and have effects of dispelling wind-heat, clearing head and eyes, relieving sore throat, promoting eruption, dispersing stagnated liver qi and promoting qi circulation; has effects in promoting digestion and tranquilizing.
Wherein, the radish seed: has the functions of promoting digestion, eliminating stagnation, lowering qi and eliminating phlegm.
The further improved scheme is as follows: the medicinal and edible coated red granules for varicose vein of lower limbs comprise the following raw materials in parts by weight: 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint.
The further improved scheme is as follows: the medicinal and edible coated red granules for varicose vein of lower limbs comprise the following raw materials in parts by weight: 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint.
The further improved scheme is as follows: the medicinal and edible coated red granules for varicose vein of lower limbs comprise the following raw materials in parts by weight: raspberry 1 part, crocus sativus 5 parts, kudzu vine root 1 part, mulberry fruit 3 parts, radish seed 1 part, allium macrostemon 3 parts and mint 1 part.
The further improved scheme is as follows: the medicinal and edible coated red granules for varicose vein of lower limbs comprise the following raw materials in parts by weight: 5 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 1 part of mulberry fruit, 5 parts of radish seed, 1 part of allium macrostemon and 3 parts of mint.
In a second aspect, the invention provides a preparation method of medicinal and edible coated red granules for varicose vein of lower limbs, which comprises the following steps:
taking 1-5 parts by weight of raspberry, 1-5 parts by weight of crocus sativus, 1-3 parts by weight of kudzu root, 1-3 parts by weight of mulberry fruit, 1-5 parts by weight of radish seed, 1-3 parts by weight of allium macrostemon and 1-3 parts by weight of mint to obtain a raw material composition;
adding 1900-2100 parts by volume of water into the raw material composition, decocting for 48-52min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1400-1600 parts by volume of water into the residues, decocting for 48-52min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
The weight parts are as follows: 1 part by volume 20 g: 1 ml.
The further improved scheme is as follows: the preparation method of the medicinal and edible coated red granules for varicose vein of lower limb comprises the following steps:
taking 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
The further improved scheme is as follows: the preparation method of the medicinal and edible coated red granules for varicose vein of lower limb comprises the following steps:
taking 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
The further improved scheme is as follows: the auxiliary materials comprise dextrin and lactose, and the weight ratio of the dextrin to the lactose is 1: 1.5. the main function of the dextrin is to shape the coated red particles and the main function of the lactose is to adjust the taste.
The invention has the beneficial effects that:
the red-coated particles are mainly prepared from seven edible homologous medicines of raspberry, saffron, mulberry fruit, kudzu vine root, allium macrostemon, mint and radish seed, and have the main effects of activating blood and dissolving stasis, blocking blood stasis, relaxing channels and activating collaterals and nourishing liver and kidney; can be used for treating lower limb venous distension, limb soreness, swelling, pain, subcutaneous stasis, induration, and edema. Can exert the advantages of less adverse reaction, good safety, obvious curative effect and the like of the traditional Chinese medicine. In addition, the medicament is prepared from seven edible homologous medicaments of the saffron, the mulberry fruit, the kudzuvine root, the allium macrostemon, the mint and the radish seed, and has no side effect basically.
In addition, under the guidance of the theory of traditional Chinese medicine, the invention optimizes the extraction process of the traditional Chinese medicine in the prescription of the red-coated granules, and determines that the optimal test scheme for preparing the red-coated granules is that the dosage ratio of the traditional Chinese medicine extract powder to the auxiliary material is 1:1 (the ratio has obvious influence on the yield of the red-coated granules), wherein the ratio of dextrin to lactose in the auxiliary material is 1: 1.5. Meanwhile, the content of rutin and gallic acid in the particles is determined by using a UPLC-MS/MS method, and the content is used as a quality detection standard of the coated red particles so as to provide a theoretical basis for industrial production of the coated red particles.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments of the invention without inventive step, are within the scope of the invention.
The first embodiment is as follows:
the embodiment provides a medicine-food homologous red-coated particle for varicose vein of lower limbs, which comprises the following raw materials in parts by weight: 1-5 parts of raspberry, 1-5 parts of crocus sativus, 1-3 parts of kudzu root, 1-3 parts of mulberry fruit, 1-5 parts of radish seed, 1-3 parts of allium macrostemon and 1-3 parts of mint.
Example two:
the medicine-food homologous Fuhong granules for varicose vein of lower limb provided by the embodiment comprise the following raw materials in parts by weight: 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint.
Example three:
the medicine-food homologous Fuhong granules for varicose vein of lower limb provided by the embodiment comprise the following raw materials in parts by weight: 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint.
Example four:
the medicine-food homologous Fuhong granules for varicose vein of lower limb provided by the embodiment comprise the following raw materials in parts by weight: raspberry 1 part, crocus sativus 5 parts, kudzu vine root 1 part, mulberry fruit 3 parts, radish seed 1 part, allium macrostemon 3 parts and mint 1 part.
Example five:
the medicine-food homologous Fuhong granules for varicose vein of lower limb provided by the embodiment comprise the following raw materials in parts by weight: 5 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 1 part of mulberry fruit, 5 parts of radish seed, 1 part of allium macrostemon and 3 parts of mint.
Example six:
the embodiment provides a preparation method of medicinal and edible coated red granules for varicose vein of lower limbs, which comprises the following steps:
taking 1-5 parts by weight of raspberry, 1-5 parts by weight of crocus sativus, 1-3 parts by weight of kudzu root, 1-3 parts by weight of mulberry fruit, 1-5 parts by weight of radish seed, 1-3 parts by weight of allium macrostemon and 1-3 parts by weight of mint to obtain a raw material composition;
adding 1900-2100 parts by volume of water into the raw material composition, decocting for 48-52min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1400-1600 parts by volume of water into the residues, decocting for 48-52min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
The weight parts are as follows: 1 part by volume 20 g: 1 ml.
Wherein the auxiliary materials comprise dextrin and lactose, and the weight ratio of the dextrin to the lactose is 1: 1.5.
Example seven:
the preparation method of the medicinal and edible coated red particles for varicose vein of lower limbs provided by the embodiment comprises the following steps:
taking 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
Wherein the auxiliary materials comprise dextrin and lactose, and the weight ratio of the dextrin to the lactose is 1: 1.5.
Example eight:
the preparation method of the medicinal and edible coated red particles for varicose vein of lower limbs provided by the embodiment comprises the following steps:
taking 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the Chinese medicinal extract powder with adjuvants at a weight ratio of 1:1, adding 70% wetting agent ethanol, and making into wet granule; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
Wherein the auxiliary materials comprise dextrin and lactose, and the weight ratio of the dextrin to the lactose is 1: 1.5.
The invention is further illustrated below in connection with the tests:
1 materials and reagents
1.1 materials
The experimental materials of raspberry, saffron, kudzu root, longstamen onion bulb, hawthorn, mint, mulberry and the like are provided by agriculture science research institute in Jinhua city, and all meet the regulations of the first part of the 2020 edition of Chinese pharmacopoeia and related items.
Rutin and gallic acid are from Tianjin Shijioyao scientific development Limited; methanol and acetonitrile are chromatographically pure; the rest reagents are analytically pure reagents.
1.2 instruments
Instrument Waters XevoTQ-S UPLC-MS/MS (FIS. Provisions.) Waters corporation, USA; tissue homogenizers (IKA, germany); Milli-Q ultrapure water purification systems (Millipore, USA); BSA2202S electronic balance (sartorius, germany); 101-2 model intelligent digital display air-blast oven, Shanghai Xinyi Instrument Co., Ltd.
2 methods and results
2.1 preparation of Red-covered granules
2.1.1 preparation of Chinese medicinal extract powder
Accurately weighing 325g of Chinese medicinal powder (Rubi fructus: stigma croci Sativi: radix Puerariae: Mori fructus: Raphani semen: Bulbus Allii Macrostemi: herba Menthae) at mass ratio of 3: 1: 3: 1), adding 2000mL of water, decocting for 50min (with boiling time), cooling, filtering, adding 1500mL of water into residue, decocting for 50min, cooling, filtering, mixing filtrates, concentrating under reduced pressure to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder.
2.1.2 orthogonal optimization test design for adjuvant compounding
Taking the mixing auxiliary material ratio (dextrin: lactose), the dosage ratio of the traditional Chinese medicine extract powder to the auxiliary material, the ethanol concentration of a wetting agent and the drying temperature as influencing factors, and designing an L9(34) orthogonal test at three levels of each factor. See table 1. Taking the granule yield as a reference index of the result, the coated red granules are placed in a 10-mesh (No. 1 sieve) and sieved for 5min, and then placed in an 80-mesh (No. 5 sieve) and sieved for 5 min. The results of the orthogonal tests are shown in tables 2 and 3. (yield (%) ═ weight of granules between sieve No. 1 and sieve No. 5)/total weight of granules × 100%).
TABLE 1 preparation level factor table for coated red granules
Level of | Adjuvant materials ratio (dextrin: lactose) | The dosage ratio of the extract powder to the auxiliary materials | Wetting agent ethanol concentration/%) | Drying temperature/. degree.C |
1 | 1∶1 | 1∶0.5 | 60 | 55 |
2 | 1∶1.5 | 1∶1 | 70 | 65 |
3 | 1∶3 | 1∶2 | 80 | 75 |
2.2 screening the auxiliary materials of the red-covered granules
2.2.1 analysis of orthogonal experimental results of compounding ratio of red-coated granule adjuvants
According to the analysis of the L9(34) orthogonal test result of the red-coated particle preparation, the traditional Chinese medicine extract powder and the auxiliary materials (raw and auxiliary material ratio) have significant difference on the yield of the red-coated particle preparation. The wetting agent ethanol concentration and the particle drying temperature have little influence on the yield of the prepared red-covered particles.
Through analysis of variance and experimental analysis, the optimal test scheme for preparing the red-coated granules is determined to be that the dosage ratio of the traditional Chinese medicine extract powder to the auxiliary materials is 1:1, wherein the ratio of dextrin to lactose in the auxiliary materials is 1:1.5, the concentration of the wetting agent ethanol is 70%, and the drying temperature of the granules is 55 ℃.
2.2.2 Fuhong granule adjuvant ratio verification experiment
The dosage ratio of the traditional Chinese medicine extract powder to the auxiliary materials is 1: 1; wherein the ratio of dextrin to lactose in the auxiliary materials is 1: 1.5; the concentration of the wetting agent ethanol is 70 percent; the drying temperature of the pellets was 55 ℃ and 3 replicates were performed. The percent of pass of the red-covered granules was determined, with an average percent of pass of 94.6% and an RSD of 0.85%. The optimization result of the process is reliable, and the yield of the red-covered particles can be effectively predicted.
TABLE 2 results of orthogonal experiments
Serial number | Ratio of auxiliary materials | Ointment auxiliary ratio | Concentration of ethanol | Drying temperature | Yield of |
1 | 1 | 1 | 1 | 1 | 79.34 |
2 | 1 | 2 | 2 | 2 | 83.45 |
3 | 1 | 3 | 3 | 3 | 74.45 |
4 | 2 | 1 | 2 | 3 | 89.23 |
5 | 2 | 2 | 3 | 1 | 94.21 |
6 | 2 | 3 | 1 | 2 | 83.67 |
7 | 3 | 1 | 3 | 2 | 88.45 |
8 | 3 | 2 | 1 | 3 | 85.74 |
9 | 3 | 3 | 2 | 1 | 91.34 |
Mean value 1 | 79.080 | 85.673 | 82.917 | 88.297 | |
Mean value 2 | 89.037 | 87.800 | 88.007 | 85.190 | |
Mean value 3 | 88.510 | 83.153 | 85.703 | 83.140 | |
Extreme difference | 9.957 | 4.647 | 5.090 | 5.517 |
TABLE 3 analysis of variance
Sources of variance | Sum of squares of class III | Degree of freedom | Mean square | F | Significance of |
Compounding ratio of auxiliary materials | 521.078 | 2 | 260.539 | 425.666 | <0.05 |
Raw material to auxiliary material ratio | 81.072 | 2 | 40.536 | 66.227 | <0.01 |
Alcohol concentration | 103.053 | 2 | 51.526 | 84.183 | >0.05 |
Drying temperature | 107.953 | 2 | 53.977 | 88.186 | >0.05 |
2.3 assay of rutin and Gallic acid in Red-covered granule
2.3.1 chromatographic conditions
Liquid chromatography conditions: a chromatographic column: ACQUITYBEH C18 (2.1X 100mm, 1.7 μm); column temperature: 40 ℃; temperature of the sample chamber: 20 ℃; flow rate: 0.4mL min-1; mobile phase: methanol (A) and 0.1% (v/v) formic acid solution (B); gradient elution (see table 4); the sample size was 1. mu.L.
Table 4 mobile phase gradient elution procedure
Time/min | A |
0~1.5 | 10% |
1.5~4 | 10%~50% |
4~8 | 50%~90% |
8~10.5 | 90% |
10.5~10.6 | 90%~10% |
10.6~13 | 10% |
Mass spectrum conditions: (anion mode)
An ion source: electrospray ion source (ESI); ion source temperature: 150 ℃; the monitoring mode is as follows: multiple Reaction Monitoring (MRM); capillary voltage: 3.0 kV; desolventizing gas (nitrogen) temperature: 160 ℃; desolventizing air flow rate: 800L/h; flow rate of cone hole back-blowing gas (nitrogen gas): 40L/h; collision gas (argon) flow rate: 0.15 mL/min; the mass spectrum collection parameters of rutin and gallic acid in the MRM monitoring mode are shown in Table 5.
TABLE 5 Mass Spectrometry acquisition parameters of rutin and gallic acid under MRM monitoring mode
2.3.2 control solutions and sample preparation
Preparing a reference substance mixed standard solution: precisely weighing rutin and gallic acid 5.0mg respectively, dissolving in methanol, and dissolving in 50mL volumetric flask for use.
Sample preparation:
preparing a reddened water-fried sample: precisely weighing 5g of the traditional Chinese medicine formula according to 2.1.1, decocting, combining the decoction, concentrating into extract powder, diluting with methanol to 100mL, and filtering with 0.22 μm organic phase filter membrane to obtain a water-decocted red sample for later use.
Preparation of a red-covered particle sample: 1.00g of the red-coated particles prepared by the method in the seventh embodiment are precisely weighed, and the volume is adjusted to 100mL by using methanol for standby.
2.3.3 Linear relationship examination
Accurately measuring the rutin and gallic acid mixed standard solution prepared in 2.3.2 by 0.00, 1.00, 2.00, 3.00, 4.00 and 5.00mL, respectively placing in a 10mL volumetric flask, and metering the volume of methanol to the scale mark. The assay was performed according to 2.3.1 chromatographic conditions. The regression equation of rutin and gallic acid standard solution and the related coefficient are shown in table 6.
TABLE 6 regression equation of standard rutin and gallic acid solution, correlation coefficient
Standard article | Concentration range/. mu.g/ml | Regression equation | Coefficient of correlation r |
Rutin | 10~50 | Y=0.0087X+0.032 | 0.9995 |
Gallic acid | 10~50 | Y=0.0094-0.00014 | 0.9986 |
2.3.4 precision test
And (3) taking the solution obtained by diluting the rutin and gallic acid standard sample solution by 25 times, and repeatedly measuring for 6 times, wherein the RSD of the rutin and gallic acid concentration measurement results is 0.89% and 1.04% respectively, which shows that the precision of the measuring instrument is good.
2.3.5 stability test
Taking the prepared red-covered water fried sample and the red-covered particle sample, measuring once every 1h for 6 times, wherein the RSD of the red-covered water fried sample is 1.13%, and the RSD of the red-covered particle sample is 0.94%. The stability of the red-covered water-fried sample and the red-covered particle sample is good within 6 h.
2.3.6 repeatability test
6 parts of the red-coated particle sample is precisely weighed to prepare a sample solution, the contents of rutin and gallic acid are measured under the condition of an instrument, and the RSD of the content measurement results of the rutin and the gallic acid is respectively 0.45% and 0.57%, which shows that the repeatability of the method for measuring the rutin and the gallic acid is good.
2.3.7 normalized recovery test
Precisely weighing 1.00g of the coated red particle sample, performing content measurement according to instrument conditions and a measurement method, and measuring the content of three reference substances. And precisely weighing 1.00g of the same batch of red granule sample, adding 10, 15 and 20 mu g of rutin and gallic acid reference substances, and measuring the content of the rutin and gallic acid reference substances. As a result, the recovery rate of rutin and gallic acid was 99.5% (RSD was 1.4%) and 100.2% (RSD was 1.67%) on the average.
2.4 sample assay
Precisely weighing 3 batches of red-coated water decocted samples and 1g of red-coated particle samples, diluting the methanol to a constant volume of 100mL volumetric flask, and measuring the contents of rutin and gallic acid by a UPLCMS/MS method, wherein the results are shown in Table 7.
TABLE 7 determination results of rutin and gallic acid content in inula red
The following tests can be carried out:
the proportion of the red-coated particles to the auxiliary materials; the optimal preparation process of the red-coated granules comprises the following steps of taking the ratio of dextrin to lactose, the ethanol concentration of a wetting agent and the drying temperature of granules in auxiliary materials as influencing factors, and performing orthogonal test: the ratio of the traditional Chinese medicine extract powder to the auxiliary materials is 1:1, wherein the ratio of dextrin to lactose in the auxiliary materials is 1:1.5, the concentration of the wetting agent ethanol is 70%, and the drying temperature of the granules is 55 ℃.
Compared with the traditional water decoction of the red-coated particles, the content of rutin and gallic acid in the red-coated particles is reduced to some extent, but the reduction amount is within 8 percent, and the red-coated particles have little influence on the treatment of varicose vein of lower limbs.
Rutin and gallic acid are one of the effective components of flavonoids in the red-coated particles, and can remove free radicals, inhibit lipid peroxidation and improve hemodynamics. The test uses rutin and gallic acid as reference substances to measure the content of the rutin and the gallic acid by an UPLCMS/MS method, and the method meets the requirement of measuring the content of the red-coated particles through precision, stability, repeatability and standard-adding recovery experiments, and can provide quality basis for the quality control of the industrial production of the red-coated particles.
The invention is further illustrated below with reference to the effect of the patient taking the enrobed granules prepared in example seven:
the traditional Chinese medicine coated red granules for treating varicose vein of lower limb are dried in an oven for 3 hours at 70 ℃, mixed uniformly, ground into powder and bagged, and each bag contains 30 g of the powder.
The using method comprises the following steps: the product can be taken after being mixed with boiling water, and can be taken as a main food after being taken with three meals every day.
And (4) index observation: and (3) observing and analyzing the lower limb swelling score, the blood stasis score, the subcutaneous induration score, the skin ulcer score numerical condition, the life quality score and the life self-care ability score numerical condition of the patient before and after the administration. Evaluating the lower limb swelling score according to 4 grades, wherein the score is 0-3, and when the score is 0, no lower limb swelling symptom is shown; when the score is 1, mild lower limb swelling symptoms are indicated; a score of 2 indicates moderate lower limb swelling; when the score was 3, the symptom of severe lower limb swelling was indicated. Evaluating the blood stasis score according to 4 grades, wherein the score is 0-3, and when the score is 0, the blood stasis symptom is represented; a score of 1 indicates mild blood stasis; a score of 2 indicates moderate blood stasis; a score of 3 indicates severe blood stasis. Evaluating subcutaneous induration scores according to 4 grades, and scoring for 0-3 points; when the score is 0, no subcutaneous induration symptom is indicated; a score of 1 indicates mild subcutaneous induration; a score of 2 indicates moderate subcutaneous induration symptoms; when the score was 3, severe subcutaneous induration symptoms were indicated. Evaluating the skin ulcer score according to 4 grades, wherein the score is 0-3, and when the score is 0, no skin ulcer symptom is shown; when the score is 1, mild skin ulcer symptoms are indicated; a score of 2 indicates moderate skin ulcer symptoms; when the score was 3, severe skin ulcer symptoms were indicated. Evaluating the life quality according to a life quality rating scale, wherein the scale is 0-100 points; the higher the score obtained by evaluation, the better the life quality performance; the lower the score obtained from the assessment, the worse the quality of life performance. Evaluating the self-care ability of life according to a self-care ability rating scale, wherein the scale is 0-100 points; the higher the score obtained by evaluation is, the higher the life self-care ability performance is; the lower the score obtained from the assessment, the lower the performance of the self-care ability of life.
The numerical conditions of the lower limb swelling score, the blood stasis score, the subcutaneous induration score and the skin ulcer score of the four weeks before and after the red-coated traditional Chinese medicine for treating varicose vein of the lower limb prepared in the seventh embodiment are used for 50 patients: after the medicine is taken, the values of the lower limb swelling score, the blood stasis score, the subcutaneous induration score and the skin ulcer score of the patient are lower than those before the medicine is taken, and the difference has statistical significance (P is less than 0.05), which is shown in Table 8.
TABLE 8 comparison of Effect before and after taking the coated Red granule prepared in EXAMPLE VII
Before and after administration | Lower limb swelling scoring | Blood stasis score | Subcutaneous induration score | Skin ulcer score |
After being used (n is 50) | 0.87±0.15 | 0.86±0.09 | 0.89±0.12 | 0.68±0.11 |
Before medicine (n is 50) | 2.23±0.16 | 1.77±0.14 | 1.97±0.12 | 1.44±0.14 |
t | 6.322 | 6.456 | 6.238 | 6.432 |
P | <0.05 | <0.05 | <0.05 | <0.05 |
And (4) conclusion: the red-coated traditional Chinese medicine granules for treating varicose vein of lower limb prepared by the embodiment seven can effectively relieve the symptoms of swelling of lower limb, blood stasis, subcutaneous induration and skin ulcer of patients with varicose vein of lower limb.
The numerical conditions of the lower limb swelling score, the blood stasis score, the subcutaneous induration score and the skin ulcer score before and after four weeks of the traditional Chinese medicine coated red particles for treating varicose veins of the lower limbs prepared in the example eight are used for 50 patients: after the medicine is taken, the values of the lower limb swelling score, the blood stasis score, the subcutaneous induration score and the skin ulcer score of the patient are lower than those before the medicine is taken, and the difference has statistical significance (P is less than 0.05), which is shown in table 9.
TABLE 9 comparison of the effect before and after taking the red-coated granules prepared in example eight
Before and after administration | Lower limb swelling scoring | Blood stasis score | Subcutaneous induration score | Skin ulcer score |
After being used (n is 50) | 0.95±0.08 | 0.84±0.17 | 0.76±0.14 | 0.72±0.03 |
Before medicine (n is 50) | 2.38±0.16 | 1.85±0.21 | 2.04±0.08 | 1.63±0.11 |
t | 6.423 | 6.357 | 6.664 | 6,348 |
P | <0.05 | <0.05 | <0.05 | <0.05 |
And (4) conclusion: the red-coated traditional Chinese medicine granules for treating varicose vein of lower limb prepared in the embodiment eight can effectively relieve the symptoms of swelling of lower limb, blood stasis, subcutaneous induration and skin ulcer of patients with varicose vein of lower limb.
The invention is not limited to the above alternative embodiments, and any other various forms of products can be obtained by anyone in the light of the present invention, but any changes in shape or structure thereof, which fall within the scope of the present invention as defined in the claims, fall within the scope of the present invention.
Claims (9)
1. The medicinal and edible coated red granules for varicose vein of lower limbs are characterized by comprising the following raw materials in parts by weight: 1-5 parts of raspberry, 1-5 parts of crocus sativus, 1-3 parts of kudzu root, 1-3 parts of mulberry fruit, 1-5 parts of radish seed, 1-3 parts of allium macrostemon and 1-3 parts of mint.
2. The medicine-food homologous red-coated particle for varicose vein of lower limbs of claim 1, which is characterized by comprising the following raw materials in parts by weight: 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint.
3. The medicine-food homologous red-coated particle for varicose vein of lower limbs of claim 1, which is characterized by comprising the following raw materials in parts by weight: 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint.
4. The medicine-food homologous red-coated particle for varicose vein of lower limbs of claim 1, which is characterized by comprising the following raw materials in parts by weight: raspberry 1 part, crocus sativus 5 parts, kudzu vine root 1 part, mulberry fruit 3 parts, radish seed 1 part, allium macrostemon 3 parts and mint 1 part.
5. The medicine-food homologous red-coated particle for varicose vein of lower limbs of claim 1, which is characterized by comprising the following raw materials in parts by weight: 5 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 1 part of mulberry fruit, 5 parts of radish seed, 1 part of allium macrostemon and 3 parts of mint.
6. A preparation method of medicinal and edible coated red granules for varicose vein of lower limb is characterized by comprising the following steps:
taking 1-5 parts by weight of raspberry, 1-5 parts by weight of crocus sativus, 1-3 parts by weight of kudzu root, 1-3 parts by weight of mulberry fruit, 1-5 parts by weight of radish seed, 1-3 parts by weight of allium macrostemon and 1-3 parts by weight of mint to obtain a raw material composition;
adding 1900-2100 parts by volume of water into the raw material composition, decocting for 48-52min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1400-1600 parts by volume of water into the residues, decocting for 48-52min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the traditional Chinese medicine extract powder and auxiliary materials according to the weight ratio of 1:1, and adding 70% of wetting agent ethanol to prepare wet granules; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
The weight parts are as follows: 1 part by volume 20 g: 1 ml.
7. The preparation method of the medicinal and edible red-coated particle for varicose vein of lower limb according to claim 6, which is characterized by comprising the following steps:
taking 3 parts of raspberry, 1 part of saffron, 3 parts of kudzuvine root, 3 parts of mulberry fruit, 1 part of radish seed, 1 part of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the traditional Chinese medicine extract powder and auxiliary materials according to the weight ratio of 1:1, and adding 70% of wetting agent ethanol to prepare wet granules; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
8. The preparation method of the medicinal and edible red-coated particle for varicose vein of lower limb according to claim 6, which is characterized by comprising the following steps:
taking 4 parts of raspberry, 1 part of saffron, 4 parts of kudzuvine root, 2 parts of mulberry fruit, 1 part of radish seed, 2 parts of allium macrostemon and 1 part of mint to obtain a raw material composition;
adding 2000 parts by volume of water into the raw material composition, decocting for 50min under a boiling condition, cooling, and filtering to obtain medicine residues;
adding 1500 parts by volume of water into the residues, decocting for 50min under boiling condition, cooling and compressing to obtain brown viscous paste, and drying to obtain Chinese medicinal extract powder;
mixing the traditional Chinese medicine extract powder and auxiliary materials according to the weight ratio of 1:1, and adding 70% of wetting agent ethanol to prepare wet granules; drying the wet granules at the temperature of 55 ℃ and finishing granules to obtain the medicinal and edible red-coated granules.
9. The preparation method of the medicinal and edible coated red particle for varicose vein of lower limbs as claimed in any one of claims 6 to 8, wherein the auxiliary material comprises dextrin and lactose in a weight ratio of 1: 1.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111587897.9A CN114028493B (en) | 2021-12-23 | 2021-12-23 | Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111587897.9A CN114028493B (en) | 2021-12-23 | 2021-12-23 | Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114028493A true CN114028493A (en) | 2022-02-11 |
CN114028493B CN114028493B (en) | 2022-08-16 |
Family
ID=80140993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111587897.9A Active CN114028493B (en) | 2021-12-23 | 2021-12-23 | Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028493B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751633A (en) * | 2013-12-31 | 2014-04-30 | 青岛恒波仪器有限公司 | Traditional Chinese medicinal composition for treating varicose vein of lower limb and preparation method thereof |
CN105395779A (en) * | 2015-12-26 | 2016-03-16 | 哈尔滨和谐旺科技开发有限公司 | Traditional Chinese medicine for efficiently treating varicosity and preparation method thereof |
CN105641051A (en) * | 2014-11-12 | 2016-06-08 | 颜菲 | Cold coagulation and blood stasis type lower limb varicosis treating traditional Chinese medicine formula |
-
2021
- 2021-12-23 CN CN202111587897.9A patent/CN114028493B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751633A (en) * | 2013-12-31 | 2014-04-30 | 青岛恒波仪器有限公司 | Traditional Chinese medicinal composition for treating varicose vein of lower limb and preparation method thereof |
CN105641051A (en) * | 2014-11-12 | 2016-06-08 | 颜菲 | Cold coagulation and blood stasis type lower limb varicosis treating traditional Chinese medicine formula |
CN105395779A (en) * | 2015-12-26 | 2016-03-16 | 哈尔滨和谐旺科技开发有限公司 | Traditional Chinese medicine for efficiently treating varicosity and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114028493B (en) | 2022-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041209B (en) | Chinese herbal preparation for curing deficiency of kidney-yin and preparation method thereof | |
CN104784673A (en) | Traditional Chinese medicine navel paste for treating infantile diarrhea | |
CN104815295A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
CN114028493B (en) | Medicinal and edible coated red granules for varicose vein of lower limb and preparation method thereof | |
WO2019104931A1 (en) | Traditional chinese medicine composition for treating leukaemia and preparation method therefor | |
CN103845450A (en) | Application of hawthorns in preparing medicine for treating hyperuricemia, gout and renal insufficiency | |
CN103404850B (en) | Beauty nourishing health food | |
CN105535839A (en) | Traditional Chinese medicine tablets for treating colon cancer and preparation method thereof | |
CN109758500A (en) | A kind of green blood cream and its preparation method and application that low dose is in good taste | |
CN116808138B (en) | Natto composition for regulating intestines and stomach and reducing blood fat and application thereof | |
CN108815226A (en) | A kind of gynemetrics's drug and preparation method thereof for treating endocrine disorder | |
CN114504619B (en) | Traditional Chinese medicine composition for treating atopic dermatitis | |
JP6708916B1 (en) | Zhuang family pharmaceutical composition for regulating replenishment and method for preparing the same | |
CN102579713B (en) | Traditional Chinese medicine for treating children obesity and preparation method | |
CN105727243A (en) | Chinese herbal composition for treating myocarditis and preparing method of Chinese herbal composition | |
CN105582379A (en) | Traditional Chinese medicine composition for treating liver-stomach disharmony and preparation method of traditional Chinese medicine composition | |
CN104547504A (en) | Heat-clearing and yin-nourishing rice bran oil as well as preparation method and application thereof | |
CN115381877A (en) | A topical skin preparation for treating acne, and its preparation method | |
CN105147861A (en) | Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation | |
CN104826080A (en) | Traditional Chinese medicine preparation for treating angina pectoris | |
CN117717599A (en) | Traditional Chinese medicine composition for relieving physical fatigue and preparation method and application thereof | |
CN114469845A (en) | External preparation using vespid wasp needle liquid and preparation method thereof | |
CN104257813A (en) | Traditional Chinese medicine composition for conditioning vital energy and blood and preparation method of traditional Chinese medicine composition | |
CN114588226A (en) | A Chinese medicinal composition for treating fracture, and its preparation method | |
CN104001025A (en) | Traditional Chinese medicine for treating chronic nephritis qi and yin deficiency and damp-heat syndrome and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |